Cataract surgery, understandably causes anxiety to anyone needing or considering this procedure. Patients hear “there is nothing to it” but every patient knows that there are potential problems. If there were not potential problems, they would not need to undergo and sign an “informed consent.” My patient offers a HIPAA-compliant and Social Media-compliant in-depth analysis of her care at Duke Eye Center in Durham, NC. In her case, we addressed her pre-existing retinal surgery, high degree of myopia and astigmatism, and her anxiety. This involved the Femtosecond LenSx LASER, Verion precision, ORA intraoperative wavefront aberommetry confirmation, and a premium toric […]
VA Outcomes and Prognostic Factors Following Phacoemulsification Cataract Surgery in Patients with Diabetes
In Denmark, investigators performed a cohort study to assess visual acuity outcomes after phacoemulsification cataract surgery in a large population of diabetic patients with all degrees of diabetic retinopathy. This review of prospectively collected data comprised patients who had small-incision phacoemulsification cataract surgery between 1999 and 2008 (10 years) according to the Danish National Patient Registry.
The investigators reviewed the data of 7,323 diabetic patients. They noted that of these patients, 285 had cataract surgery. They found that the corrected distance visual acuity (CDVA) increased significantly after cataract surgery […]
A great overview from the AAO is as follows:
LASIK (laser-assisted in situ keratomileusis) is an outpatientrefractive surgery procedure used to treat nearsightedness,farsightedness and astigmatism. A laser is used to reshape the cornea — the clear, round dome at the front of the eye — to improve the way the eye focuses light rays onto the retina at the back of the eye.
With LASIK, an ophthalmologist (Eye M.D.) creates a thin flap in the cornea using either a blade or a laser. The surgeon folds back the flap and precisely removes a very specific amount of corneal tissue under the flap using an excimer laser. […]
The Refractive Surgery program at the Duke Eye Center and the Duke Center for Vision Correction successfully completed the 14th annual VISX Laser Certification Course making it now the longest running “in house” program in the nation for training and certifying surgeons to perform PRK and LASIK using the VISX Laser. Alan Carlson, M.D., Professor of Ophthalmology at Duke has given this program each year at Duke which begins with a 5 hour didactic session reviewing 252 slides and quizzing the participants along the way to make sure they grasp the concepts. There is strict adherence to the FDA guidelines […]
Reflecting on my time with Sir Harold Ridley and the present debate over Monofocal vs Multifocal IOLs
The great debate: Monofocal vs. multifocal
by Jena Passut EyeWorld Staff Writer
Ever since Nov. 29, 1949, when Sir Harold Ridley, M.D., F.R.S., first successfully implanted an IOL in a patient in a London hospital, surgeons have researched, debated, and sometimes obsessed over the best surgical lens to use.
Nearly 62 years later and after many advances in the surgical technique and the lenses themselves, the discussion continues—this time over multifocal versus monofocal IOL implants for presbyopia correction.
While monofocal IOLs are still considered the standard, especially in distance vision, advocates for the latest in multifocal implants say that patients’ push for spectacle […]
Cataracts sufferers forced to wait longer for treatment
Hundreds of thousands of people with cataracts will have to wait longer for treatment due to cost-cutting changes by health authorities, a survey indicates.
A poll of GPs has found more than a quarter of them (27 per cent) said recent changes to qualifying criteria by primary care trusts meant patients would have to wait for their eyesight to deteriorate further before getting surgery on the NHS.
Some 720,000 people are diagnosed with cataracts each month, which leave sufferers with blurred vision.
But the eye treatment company Ultralase, which commissioned a survey of 100 GPs and […]
Multiple studies over the past 2 decades repeatedly demonstrate that the risks associated with discontinuation of coumadin and antiplatelet therapy in patient at high risk for thrombotic or embolic events exceed the risks associated with excessive bleeding during surgery. The attached recent study is one more study that affirms this. Patients needing more involved surgery, such as cases anticipating sutured IOLs, vitrectomy, membrane pealing, etc; however, may need to hold antiplatelet therapy in advance of this nonroutine surgery.
Risk assessment of simple phacoemulsification in patients on combined anticoagulant and antiplatelet therapy
Irina S. Barequet, MD
Corresponding author: Irina S. Barequet, MD, Goldschleger Eye […]
As pressures mount to contain the cost of health care, particularly when more people are expected to live longer, it is reasonable to look critically at the “return on investment” (ROI) and see where cataract surgery compares to other frequently performed procedures that account for substantial health care dollars. The most common method of looking at cost-utility or cost-effectiveness is the use of the QALY or quality-adjusted life year which addresses the “area under the curve” – assessing both increased quality of life and extended duration of life. For example, a year of perfect health gets a score of 1.0 […]
ANC Comment: Nice review below borrowed from an email from Expert Review.
Thoughts – We are still lacking in our understanding of how the genetically predisposed individual develops the onset and progression of keratoconus.
Why do only 7% of patients diagnosed with this genetic condition have a positive family history?
Why are they more prone to eye rubbing, floppy eyelids, weight gain, and obstructive sleep apnea?
Is corneal crosslinking, which in effect strengthens the cornea by “aging” the tissue, going to become a standard treatment option?
Should we be putting Intacs corneal ring segments in earlier to prevent progression?
Is Keratoconus a disease, a susceptibility, or […]
STAAR Surgical Announces First Visian® ICL V4c Implants in Europe
–KS-AquaPORT(TM) Pre-Launch Utilizing the Proprietary CentraFLOW(TM) Technology Begins –Eliminates a Step in the ICL Procedure Making it More Efficient and Cost Effective –Successful Visian ICL Implants Worldwide Now Surpass 225,000
MONROVIA, Calif., June 27,2011 /PRNewswire via COMTEX/ — STAAR Surgical Company STAA +0.19% , the leading developer, manufacturer and marketer of minimally invasive refractive lenses that go inside the eye, today announced the completion of the first procedures to implant its recently CE Mark-approved Visian® Implantable Collamer® Lens (ICL(TM)) V4c design. Dr. Erik Mertens, Medical Director and founder of the […]